| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 24 | 2024 | 152 | 5.060 |
Why?
|
| Asthma | 22 | 2022 | 955 | 3.450 |
Why?
|
| Pneumothorax | 9 | 2024 | 52 | 3.130 |
Why?
|
| Bronchi | 9 | 2019 | 229 | 2.210 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 5 | 2024 | 12 | 2.210 |
Why?
|
| Pulmonary Emphysema | 5 | 2024 | 30 | 2.150 |
Why?
|
| Lung Neoplasms | 15 | 2024 | 2261 | 2.140 |
Why?
|
| Solitary Pulmonary Nodule | 3 | 2021 | 138 | 1.930 |
Why?
|
| Catheter Ablation | 7 | 2022 | 233 | 1.850 |
Why?
|
| Lung Diseases | 4 | 2019 | 263 | 1.380 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2024 | 247 | 1.300 |
Why?
|
| Pneumonectomy | 5 | 2024 | 196 | 1.280 |
Why?
|
| Respiratory Tract Fistula | 2 | 2017 | 9 | 1.050 |
Why?
|
| Emphysema | 3 | 2021 | 22 | 0.980 |
Why?
|
| Robotic Surgical Procedures | 3 | 2024 | 267 | 0.930 |
Why?
|
| Fluoroscopy | 2 | 2021 | 119 | 0.830 |
Why?
|
| Pulmonary Medicine | 2 | 2019 | 46 | 0.800 |
Why?
|
| Prostheses and Implants | 3 | 2019 | 121 | 0.770 |
Why?
|
| Endosonography | 5 | 2022 | 96 | 0.730 |
Why?
|
| Humans | 74 | 2024 | 86601 | 0.720 |
Why?
|
| Airway Obstruction | 2 | 2019 | 109 | 0.680 |
Why?
|
| Sarcoidosis | 5 | 2016 | 71 | 0.610 |
Why?
|
| Pleural Diseases | 1 | 2017 | 13 | 0.600 |
Why?
|
| Bronchial Diseases | 1 | 2016 | 12 | 0.560 |
Why?
|
| Tracheobronchomalacia | 1 | 2016 | 11 | 0.550 |
Why?
|
| Laryngostenosis | 1 | 2016 | 16 | 0.550 |
Why?
|
| Postoperative Complications | 3 | 2016 | 2207 | 0.550 |
Why?
|
| Tracheal Stenosis | 1 | 2016 | 23 | 0.550 |
Why?
|
| Societies, Medical | 2 | 2019 | 572 | 0.550 |
Why?
|
| Bronchial Thermoplasty | 3 | 2021 | 6 | 0.540 |
Why?
|
| Radiographic Image Enhancement | 1 | 2018 | 462 | 0.540 |
Why?
|
| Hot Temperature | 1 | 2016 | 206 | 0.530 |
Why?
|
| Treatment Failure | 2 | 2013 | 285 | 0.490 |
Why?
|
| Libraries, Digital | 1 | 2013 | 2 | 0.490 |
Why?
|
| Libraries, Medical | 1 | 2013 | 5 | 0.480 |
Why?
|
| Quality of Life | 9 | 2024 | 1583 | 0.480 |
Why?
|
| Palliative Care | 1 | 2016 | 257 | 0.470 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2021 | 1074 | 0.450 |
Why?
|
| Lung | 7 | 2024 | 1170 | 0.440 |
Why?
|
| Chest Tubes | 3 | 2024 | 23 | 0.440 |
Why?
|
| alpha 1-Antitrypsin | 3 | 2024 | 16 | 0.430 |
Why?
|
| Insurance Coverage | 1 | 2013 | 115 | 0.430 |
Why?
|
| Forced Expiratory Volume | 4 | 2024 | 122 | 0.420 |
Why?
|
| Prospective Studies | 10 | 2024 | 4210 | 0.420 |
Why?
|
| Internet | 1 | 2013 | 312 | 0.400 |
Why?
|
| Image-Guided Biopsy | 3 | 2021 | 65 | 0.390 |
Why?
|
| Medicare | 1 | 2013 | 406 | 0.360 |
Why?
|
| Female | 37 | 2022 | 44507 | 0.350 |
Why?
|
| Genetic Testing | 2 | 2016 | 535 | 0.340 |
Why?
|
| Cholinergic Antagonists | 1 | 2009 | 26 | 0.340 |
Why?
|
| Electromagnetic Phenomena | 3 | 2024 | 18 | 0.340 |
Why?
|
| Middle Aged | 28 | 2021 | 25017 | 0.330 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2017 | 121 | 0.310 |
Why?
|
| Ablation Techniques | 2 | 2019 | 34 | 0.310 |
Why?
|
| Male | 33 | 2021 | 40956 | 0.310 |
Why?
|
| Smoking Cessation | 1 | 2010 | 230 | 0.300 |
Why?
|
| Motivation | 1 | 2010 | 287 | 0.300 |
Why?
|
| Treatment Outcome | 12 | 2024 | 7988 | 0.290 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2004 | 231 | 0.280 |
Why?
|
| Biopsy | 4 | 2019 | 1161 | 0.270 |
Why?
|
| HLA-G Antigens | 2 | 2017 | 52 | 0.260 |
Why?
|
| DNA Methylation | 2 | 2022 | 628 | 0.260 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 107 | 0.250 |
Why?
|
| Dyspnea | 2 | 2024 | 73 | 0.250 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2004 | 15 | 0.250 |
Why?
|
| Bronchitis, Chronic | 1 | 2023 | 2 | 0.240 |
Why?
|
| Ventilators, Mechanical | 1 | 2004 | 33 | 0.240 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 1565 | 0.240 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 314 | 0.220 |
Why?
|
| MicroRNAs | 2 | 2021 | 534 | 0.220 |
Why?
|
| Hypnotics and Sedatives | 1 | 2004 | 125 | 0.220 |
Why?
|
| Swine | 1 | 2024 | 555 | 0.210 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1384 | 0.210 |
Why?
|
| Microbiota | 2 | 2019 | 381 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2015 | 339 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 379 | 0.210 |
Why?
|
| Interleukin-33 | 1 | 2021 | 24 | 0.210 |
Why?
|
| Risk Assessment | 5 | 2016 | 2261 | 0.210 |
Why?
|
| Software | 2 | 2018 | 654 | 0.210 |
Why?
|
| Anxiety | 1 | 2004 | 287 | 0.210 |
Why?
|
| Adult | 17 | 2022 | 25640 | 0.200 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 827 | 0.200 |
Why?
|
| Eosinophils | 2 | 2019 | 194 | 0.200 |
Why?
|
| Patient Discharge | 1 | 2024 | 300 | 0.200 |
Why?
|
| Disease Progression | 4 | 2023 | 1531 | 0.200 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 240 | 0.200 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 1169 | 0.200 |
Why?
|
| Spirometry | 2 | 2012 | 66 | 0.200 |
Why?
|
| Echocardiography | 2 | 2016 | 911 | 0.190 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2021 | 93 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 1937 | 0.190 |
Why?
|
| Electrocoagulation | 2 | 2019 | 22 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2020 | 110 | 0.180 |
Why?
|
| Epithelial Cells | 3 | 2021 | 669 | 0.180 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 266 | 0.180 |
Why?
|
| Photochemotherapy | 2 | 2019 | 97 | 0.170 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 481 | 0.170 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2019 | 62 | 0.170 |
Why?
|
| Organizational Objectives | 1 | 2019 | 27 | 0.170 |
Why?
|
| Drainage | 1 | 2020 | 157 | 0.170 |
Why?
|
| Fungi | 1 | 2019 | 65 | 0.170 |
Why?
|
| Education | 1 | 2019 | 58 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2021 | 263 | 0.170 |
Why?
|
| Proteomics | 1 | 2020 | 212 | 0.170 |
Why?
|
| Respiratory System | 1 | 2019 | 116 | 0.170 |
Why?
|
| International Cooperation | 1 | 2019 | 127 | 0.170 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 1801 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 294 | 0.160 |
Why?
|
| Th2 Cells | 1 | 2019 | 146 | 0.160 |
Why?
|
| Laser Therapy | 2 | 2019 | 142 | 0.160 |
Why?
|
| Comorbidity | 3 | 2022 | 943 | 0.160 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 185 | 0.160 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2018 | 5 | 0.160 |
Why?
|
| United States | 6 | 2021 | 6665 | 0.160 |
Why?
|
| Intraoperative Period | 1 | 2018 | 90 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2020 | 321 | 0.160 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 132 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2019 | 256 | 0.160 |
Why?
|
| Neutrophils | 1 | 2019 | 307 | 0.160 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 266 | 0.160 |
Why?
|
| Research | 1 | 2019 | 253 | 0.150 |
Why?
|
| Muscle, Smooth | 2 | 2016 | 354 | 0.150 |
Why?
|
| Intensive Care Units | 2 | 2015 | 373 | 0.150 |
Why?
|
| Pleurodesis | 1 | 2017 | 8 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2022 | 1920 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2024 | 8475 | 0.150 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 479 | 0.150 |
Why?
|
| Air | 1 | 2017 | 62 | 0.150 |
Why?
|
| Thoracoscopy | 1 | 2017 | 22 | 0.150 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 98 | 0.140 |
Why?
|
| Accreditation | 1 | 2017 | 60 | 0.140 |
Why?
|
| Mediastinal Diseases | 1 | 2016 | 21 | 0.140 |
Why?
|
| Argon Plasma Coagulation | 1 | 2016 | 6 | 0.140 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 429 | 0.140 |
Why?
|
| Granuloma | 1 | 2016 | 65 | 0.140 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2016 | 59 | 0.140 |
Why?
|
| Cryosurgery | 1 | 2016 | 40 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1034 | 0.140 |
Why?
|
| TRPC Cation Channels | 1 | 2015 | 21 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2016 | 42 | 0.140 |
Why?
|
| Aged | 12 | 2020 | 18402 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 108 | 0.140 |
Why?
|
| Phagosomes | 1 | 2015 | 39 | 0.140 |
Why?
|
| Intracellular Membranes | 1 | 2015 | 117 | 0.130 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2015 | 15 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 213 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 930 | 0.130 |
Why?
|
| Phenotype | 4 | 2022 | 2377 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2019 | 428 | 0.130 |
Why?
|
| Brachytherapy | 1 | 2016 | 119 | 0.130 |
Why?
|
| Prednisone | 1 | 2015 | 258 | 0.130 |
Why?
|
| Deglutition Disorders | 1 | 2016 | 115 | 0.130 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2015 | 68 | 0.130 |
Why?
|
| Serum Response Factor | 2 | 2004 | 44 | 0.120 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2014 | 17 | 0.120 |
Why?
|
| MEDLINE | 1 | 2013 | 8 | 0.120 |
Why?
|
| Web Browser | 1 | 2013 | 5 | 0.120 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 592 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 134 | 0.120 |
Why?
|
| Prognosis | 5 | 2021 | 3674 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2016 | 290 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3352 | 0.120 |
Why?
|
| Databases as Topic | 1 | 2013 | 92 | 0.120 |
Why?
|
| Adalimumab | 1 | 2014 | 80 | 0.120 |
Why?
|
| Thoracic Diseases | 1 | 2013 | 25 | 0.120 |
Why?
|
| Risk Factors | 3 | 2022 | 5416 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 1054 | 0.120 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2013 | 10 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2017 | 970 | 0.120 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2015 | 165 | 0.120 |
Why?
|
| Stents | 1 | 2016 | 377 | 0.110 |
Why?
|
| Disease Management | 1 | 2015 | 327 | 0.110 |
Why?
|
| Electromagnetic Fields | 1 | 2013 | 26 | 0.110 |
Why?
|
| Social Networking | 1 | 2013 | 75 | 0.110 |
Why?
|
| Feasibility Studies | 3 | 2023 | 751 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 369 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2016 | 563 | 0.110 |
Why?
|
| Medicine | 1 | 2013 | 89 | 0.110 |
Why?
|
| Time Factors | 5 | 2019 | 5209 | 0.110 |
Why?
|
| Curriculum | 1 | 2017 | 539 | 0.110 |
Why?
|
| Pacemaker, Artificial | 1 | 2013 | 87 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1981 | 0.100 |
Why?
|
| Prosthesis Design | 1 | 2013 | 278 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2016 | 395 | 0.100 |
Why?
|
| Animals | 5 | 2024 | 26581 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 288 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 663 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2022 | 3636 | 0.100 |
Why?
|
| Defibrillators, Implantable | 1 | 2013 | 129 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2600 | 0.100 |
Why?
|
| Cytokines | 3 | 2021 | 776 | 0.100 |
Why?
|
| Models, Genetic | 1 | 2015 | 926 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 219 | 0.090 |
Why?
|
| Smoking Prevention | 1 | 2010 | 43 | 0.090 |
Why?
|
| Inflammation | 1 | 2015 | 920 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 1464 | 0.090 |
Why?
|
| Respiration Disorders | 1 | 2010 | 39 | 0.090 |
Why?
|
| Histoplasmosis | 1 | 2009 | 25 | 0.090 |
Why?
|
| Respiratory Function Tests | 3 | 2015 | 136 | 0.090 |
Why?
|
| Opportunistic Infections | 1 | 2009 | 59 | 0.090 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 1169 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 1 | 2009 | 87 | 0.080 |
Why?
|
| Hematoma | 1 | 2009 | 104 | 0.080 |
Why?
|
| Administration, Inhalation | 1 | 2009 | 188 | 0.080 |
Why?
|
| Sweden | 1 | 2008 | 40 | 0.080 |
Why?
|
| Psychology | 1 | 2008 | 24 | 0.080 |
Why?
|
| Cell Line | 3 | 2015 | 2468 | 0.080 |
Why?
|
| Rats, Inbred WKY | 2 | 2004 | 31 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 166 | 0.080 |
Why?
|
| Europe | 1 | 2008 | 309 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2009 | 342 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 196 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 6501 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 2356 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 162 | 0.070 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2019 | 241 | 0.070 |
Why?
|
| Topotecan | 1 | 2006 | 45 | 0.070 |
Why?
|
| Genotype | 3 | 2020 | 1850 | 0.070 |
Why?
|
| Gene Expression | 2 | 2016 | 1284 | 0.070 |
Why?
|
| Length of Stay | 2 | 2020 | 700 | 0.070 |
Why?
|
| Pulmonary Alveoli | 1 | 2006 | 71 | 0.070 |
Why?
|
| Physicians | 1 | 2013 | 673 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 2006 | 134 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 683 | 0.070 |
Why?
|
| Smoking | 1 | 2010 | 609 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 999 | 0.060 |
Why?
|
| Pulmonary Fibrosis | 1 | 2006 | 123 | 0.060 |
Why?
|
| Proteasome Inhibitors | 1 | 2004 | 51 | 0.060 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 150 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 72 | 0.060 |
Why?
|
| Quantitative Trait Loci | 2 | 2020 | 576 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 977 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2004 | 90 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 153 | 0.060 |
Why?
|
| Benzodiazepines | 1 | 2004 | 64 | 0.060 |
Why?
|
| Stroke Volume | 2 | 2016 | 456 | 0.060 |
Why?
|
| Propofol | 1 | 2004 | 89 | 0.060 |
Why?
|
| Narcotics | 1 | 2004 | 69 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 2767 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2017 | 1538 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2004 | 345 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1804 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 692 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 1185 | 0.050 |
Why?
|
| Adult Children | 1 | 2022 | 12 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 696 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2022 | 32 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 268 | 0.050 |
Why?
|
| Japan | 1 | 2022 | 307 | 0.050 |
Why?
|
| Microwaves | 1 | 2022 | 34 | 0.050 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2021 | 17 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 2270 | 0.050 |
Why?
|
| CpG Islands | 1 | 2022 | 151 | 0.050 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2021 | 20 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 74 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 1990 | 0.050 |
Why?
|
| Pain | 1 | 2004 | 391 | 0.050 |
Why?
|
| Mediastinum | 1 | 2021 | 46 | 0.050 |
Why?
|
| Calibration | 1 | 2021 | 99 | 0.050 |
Why?
|
| Mothers | 1 | 2022 | 141 | 0.050 |
Why?
|
| Young Adult | 3 | 2019 | 5974 | 0.050 |
Why?
|
| Rats | 2 | 2004 | 3990 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2004 | 673 | 0.050 |
Why?
|
| Genomics | 2 | 2016 | 720 | 0.050 |
Why?
|
| Child | 2 | 2022 | 6926 | 0.050 |
Why?
|
| Inhalation | 1 | 2019 | 31 | 0.050 |
Why?
|
| Contraindications | 1 | 2019 | 72 | 0.040 |
Why?
|
| Cryotherapy | 1 | 2019 | 29 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2705 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 839 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 294 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 309 | 0.040 |
Why?
|
| Chromatin | 1 | 2021 | 380 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2020 | 473 | 0.040 |
Why?
|
| Bronchoconstriction | 1 | 2018 | 55 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 266 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 937 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 1127 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2019 | 272 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1540 | 0.040 |
Why?
|
| Prevalence | 2 | 2012 | 1239 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2009 | 293 | 0.040 |
Why?
|
| Patient Selection | 1 | 2021 | 685 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2019 | 695 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2017 | 144 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2016 | 36 | 0.040 |
Why?
|
| Itraconazole | 1 | 2016 | 11 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 532 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1673 | 0.040 |
Why?
|
| TRPC6 Cation Channel | 1 | 2015 | 5 | 0.030 |
Why?
|
| Diglycerides | 1 | 2015 | 22 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 2015 | 31 | 0.030 |
Why?
|
| Chicago | 1 | 2020 | 1379 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 589 | 0.030 |
Why?
|
| Acids | 1 | 2015 | 13 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2015 | 31 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 702 | 0.030 |
Why?
|
| Algorithms | 1 | 2004 | 1830 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2016 | 117 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 278 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 752 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 57 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 864 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 91 | 0.030 |
Why?
|
| Exocytosis | 1 | 2015 | 108 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 2015 | 55 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 61 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 108 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2015 | 84 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 316 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2015 | 129 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 2357 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 1620 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 115 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 178 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2015 | 396 | 0.030 |
Why?
|
| Weight Loss | 1 | 2016 | 229 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 596 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 411 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 392 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2020 | 1196 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 689 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 2015 | 324 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2013 | 57 | 0.030 |
Why?
|
| Polysomnography | 1 | 2013 | 151 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 307 | 0.030 |
Why?
|
| Publishing | 1 | 2013 | 90 | 0.030 |
Why?
|
| Respiratory Therapy Department, Hospital | 1 | 2012 | 1 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 88 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 666 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 364 | 0.030 |
Why?
|
| Medical Laboratory Personnel | 1 | 2012 | 4 | 0.030 |
Why?
|
| Transcriptome | 1 | 2016 | 580 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 421 | 0.030 |
Why?
|
| Bacteria | 1 | 2015 | 447 | 0.030 |
Why?
|
| Systole | 1 | 2011 | 129 | 0.030 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 167 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2017 | 751 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 476 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 1313 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1860 | 0.020 |
Why?
|
| Calcium | 1 | 2015 | 1156 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 1077 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1718 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2011 | 115 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2436 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 159 | 0.020 |
Why?
|
| Dependovirus | 1 | 2009 | 33 | 0.020 |
Why?
|
| Histoplasma | 1 | 2009 | 13 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 2009 | 38 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 529 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1749 | 0.020 |
Why?
|
| Cause of Death | 1 | 2009 | 277 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2009 | 183 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2009 | 439 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 1376 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 813 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 2501 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 3241 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 3967 | 0.020 |
Why?
|
| Dipeptides | 1 | 2004 | 46 | 0.020 |
Why?
|
| Liver | 1 | 2009 | 1229 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2004 | 179 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 498 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 11352 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1683 | 0.010 |
Why?
|